Q1 2023 13F Holders as of 31 Mar 2023
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
416,598,522
-
Total 13F shares
-
122,809,016
-
Share change
-
-1,187,019
-
Total reported value
-
$103,788,160
-
Put/Call ratio
-
57%
-
Price per share
-
$0.85
-
Number of holders
-
149
-
Value change
-
-$1,405,031
-
Number of buys
-
59
-
Number of sells
-
71
Institutional Holders of CLOVER HEALTH INVESTMENTS, CORP. /DE - Common Stock (CLOV) as of Q1 2023
As of 31 Mar 2023,
CLOVER HEALTH INVESTMENTS, CORP. /DE - Common Stock (CLOV) was held by
149 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
122,809,016 shares.
The largest 10 holders included
VANGUARD GROUP INC, BlackRock Inc., STATE STREET CORP, GEODE CAPITAL MANAGEMENT, LLC, RENAISSANCE TECHNOLOGIES LLC, PNC Financial Services Group, Inc., NORTHERN TRUST CORP, CHARLES SCHWAB INVESTMENT MANAGEMENT INC, Voya Investment Management LLC, and JUPITER ASSET MANAGEMENT LTD.
This page lists
151
institutional shareholders reporting positions in this security
for the Q1 2023 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.